Screening for coronary artery disease in diabetic patients: The DIAD study

British Journal of Diabetes and Vascular Disease

Volumn 4, Issue 5, 2004, Pages 317-319

  Inzucchi, Silvio E ^a   Young, Lawrence H ^a   Chyun, Deborah A ^b   Wackers, Frans J Th ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Coronary artery disease; Perfusion imaging; Silent ischaemia; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; INSULIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART DILATATION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SCAR FORMATION; SCREENING TEST; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY; VALSALVA MANEUVER;

EID: 7744228233     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514040040050501     Document Type: Article

References (11)

1. Nesto RW. Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care 1999;22:1393-5.
2. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991;67:1073-8.
3. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 1997;79:134-9.
4. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999;22:1396-400.
5. Valensi P, Sachs RN, Harfouche B et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 2001;24 339-43.
6. De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002;90 827-32.
7. Gazzaruso C, Garzaniti A, Giordanetti S et al. Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients. Diabetes Care 2002; 25 1418-24.
8. Faglia E, Favales F, Calia P et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 2002;25:2032-6.
9. Kang X, Berman DS, Lewin HC et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999; 138:1025-32.
10. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998;21:1551-9.
11. Wackers FJ Th, Young LH, Inzucchi SE et al. The detection of silent myocardial ischaemia in asymptomatic diabetics (DIAD) study. Diabetes Care 2004;27:1954-61.